3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Stomach Neoplasms
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Carcinoma, Renal Cell
3
Recurrence
2
Neoplasm Metastasis
2
Melanoma
2
Kidney Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Adenocarcinoma Of Esophagus
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Urothelial Bladder Carcinoma
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thymoma
1
Solid Tumors
1
Solid Tumor
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Metastatic Urothelial Cancer
1
Interventions
Magnetic Resonance Spectroscopy
13
Cisplatin
12
Specimen Handling
11
pembrolizumab
10
Radiotherapy, Intensity-Modulated
7
Cetuximab
7
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
Taxes
4
Surgical Procedures, Operative
4
Radiotherapy
4
Paclitaxel
4
Carboplatin
4
Biopsy
4
(225)Ac-DOTA-c(RGDyK)
4
Radiation
3
Chemoradiotherapy
3
ipatasertib
2
X-Rays
2
Surveys and Questionnaires
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Docetaxel
2
Disulfides
2
sacituzumab govitecan
1
peposertib
1
merphos
1
durvalumab
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hypopharyngeal Neoplasms
×
zimberelimab
×
1 year
×
Clear all
No trials found.